「筋弛緩薬」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- カテゴリ
- 色
- 同義語オン
- 提供元
- 日付
- 24時間以内 0
- 48時間以内 0
- 72時間以内 0
- 7日以内 0
- 30日以内 0
- 1年以内 0
- 期間を指定 44
- 日付指定なし 44
- 種類
- 写真 44
- グラフィックス 0
- 映像 0
- 向き
- 縦 1
- 横 43
- 正方形 0
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー 44
- モノクロ 0
- 同義語辞書
- 古い順
- 1
- 古い順
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104832
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104836
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee adjusts mixer on granulation site in a production workshop of Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104776
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 A pressure gauge is seen on a mixer on granulation site in a production workshop of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104837
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104835
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 A tableting site is seen in workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104842
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104930
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 A view shows scales for tablets weighing in workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104922
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 A view shows scales for tablets weighing in workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104923
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104833
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104939
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee adjusts an equipment that packages tablets in blisters, at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104824
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 A view shows an equipment that packages tablets in blisters, at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104805
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 A view shows an equipment that packages tablets in blisters, at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104811
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 A view shows an equipment that packages tablets in blisters, at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104810
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104831
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104834
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104828
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104827
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104843
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104809
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An interior view shows the workshop No. 9 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104825
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104790
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104789
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104788
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 Employees work at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104778
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104928
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 A view shows thermostats at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104785
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104781
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 A view shows the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104793
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104797
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 An employee works at the quality control laboratory of workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104795
2023年03月29日Russia Pharmaceutical Industry Biokhimik29.03.2023 A view shows the workshop No. 20 of the Biokhimik plant, in Saransk, Russia. The Biokhimik facility will launch the production of 130 pharmaceutical substances, including medications to treat oncological and cardiovascular diseases and HIV, as well as antibiotics, anti-inflammatory drugs and myorelaxants. Vladimir Astapkovich / Sputnik、クレジット：Ｓｐｕｔｎｉｋ／共同通信イメージズ
商品コード: 2023040104786
2023年07月21日Pfizer Facade in New YorkJuly 21, 2023, New York City, New York: (NEW) Pfizer Facade in New York. July 21, 2023, New York, USA: Pfizer factory at Rocky Mount, in North Carolina suffered a severe storm damage due to Tornado, thus affecting its drug supply but with no employees injured. This factory is one of the largest drug manufacturing facilities in the world, producing roughly a quarter of Pfizer‘s sterile injectable medicines like anesthesia, painkillers, anti-infectives and muscle relaxants used by U.S. hospitals,.Credit: Leco Viana/Thenews2 (Foto: Leco Viana/Thenews2/Zumapress) (Credit Image: © Leco Viana/TheNEWS2 via ZUMA Press Wire)、クレジット：©Ｌｅｃｏ Ｖｉａｎａ／ＴｈｅＮＥＷＳ２ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2023072205355
2023年07月21日Pfizer Facade in New YorkJuly 21, 2023, New York City, New York: (NEW) Pfizer Facade in New York. July 21, 2023, New York, USA: Pfizer factory at Rocky Mount, in North Carolina suffered a severe storm damage due to Tornado, thus affecting its drug supply but with no employees injured. This factory is one of the largest drug manufacturing facilities in the world, producing roughly a quarter of Pfizer‘s sterile injectable medicines like anesthesia, painkillers, anti-infectives and muscle relaxants used by U.S. hospitals,.Credit: Leco Viana/Thenews2 (Foto: Leco Viana/Thenews2/Zumapress) (Credit Image: © Leco Viana/TheNEWS2 via ZUMA Press Wire)、クレジット：©Ｌｅｃｏ Ｖｉａｎａ／ＴｈｅＮＥＷＳ２ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2023072205284
2023年07月21日Pfizer Facade in New YorkJuly 21, 2023, New York City, New York: (NEW) Pfizer Facade in New York. July 21, 2023, New York, USA: Pfizer factory at Rocky Mount, in North Carolina suffered a severe storm damage due to Tornado, thus affecting its drug supply but with no employees injured. This factory is one of the largest drug manufacturing facilities in the world, producing roughly a quarter of Pfizer‘s sterile injectable medicines like anesthesia, painkillers, anti-infectives and muscle relaxants used by U.S. hospitals,.Credit: Leco Viana/Thenews2 (Foto: Leco Viana/Thenews2/Zumapress) (Credit Image: © Leco Viana/TheNEWS2 via ZUMA Press Wire)、クレジット：©Ｌｅｃｏ Ｖｉａｎａ／ＴｈｅＮＥＷＳ２ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2023072205362
2023年07月21日Pfizer Facade in New YorkJuly 21, 2023, New York City, New York: (NEW) Pfizer Facade in New York. July 21, 2023, New York, USA: Pfizer factory at Rocky Mount, in North Carolina suffered a severe storm damage due to Tornado, thus affecting its drug supply but with no employees injured. This factory is one of the largest drug manufacturing facilities in the world, producing roughly a quarter of Pfizer‘s sterile injectable medicines like anesthesia, painkillers, anti-infectives and muscle relaxants used by U.S. hospitals,.Credit: Leco Viana/Thenews2 (Foto: Leco Viana/Thenews2/Zumapress) (Credit Image: © Leco Viana/TheNEWS2 via ZUMA Press Wire)、クレジット：©Ｌｅｃｏ Ｖｉａｎａ／ＴｈｅＮＥＷＳ２ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2023072205271
2023年07月21日Pfizer Facade in New YorkJuly 21, 2023, New York City, New York: (NEW) Pfizer Facade in New York. July 21, 2023, New York, USA: Pfizer factory at Rocky Mount, in North Carolina suffered a severe storm damage due to Tornado, thus affecting its drug supply but with no employees injured. This factory is one of the largest drug manufacturing facilities in the world, producing roughly a quarter of Pfizer‘s sterile injectable medicines like anesthesia, painkillers, anti-infectives and muscle relaxants used by U.S. hospitals,.Credit: Leco Viana/Thenews2 (Foto: Leco Viana/Thenews2/Zumapress) (Credit Image: © Leco Viana/TheNEWS2 via ZUMA Press Wire)、クレジット：©Ｌｅｃｏ Ｖｉａｎａ／ＴｈｅＮＥＷＳ２ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2023072205413
2023年07月21日Pfizer Facade in New YorkJuly 21, 2023, New York City, New York: (NEW) Pfizer Facade in New York. July 21, 2023, New York, USA: Pfizer factory at Rocky Mount, in North Carolina suffered a severe storm damage due to Tornado, thus affecting its drug supply but with no employees injured. This factory is one of the largest drug manufacturing facilities in the world, producing roughly a quarter of Pfizer‘s sterile injectable medicines like anesthesia, painkillers, anti-infectives and muscle relaxants used by U.S. hospitals,.Credit: Leco Viana/Thenews2 (Foto: Leco Viana/Thenews2/Zumapress) (Credit Image: © Leco Viana/TheNEWS2 via ZUMA Press Wire)、クレジット：©Ｌｅｃｏ Ｖｉａｎａ／ＴｈｅＮＥＷＳ２ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2023072205279
2023年07月21日Pfizer Facade in New YorkJuly 21, 2023, New York City, New York: (NEW) Pfizer Facade in New York. July 21, 2023, New York, USA: Pfizer factory at Rocky Mount, in North Carolina suffered a severe storm damage due to Tornado, thus affecting its drug supply but with no employees injured. This factory is one of the largest drug manufacturing facilities in the world, producing roughly a quarter of Pfizer‘s sterile injectable medicines like anesthesia, painkillers, anti-infectives and muscle relaxants used by U.S. hospitals,.Credit: Leco Viana/Thenews2 (Foto: Leco Viana/Thenews2/Zumapress) (Credit Image: © Leco Viana/TheNEWS2 via ZUMA Press Wire)、クレジット：©Ｌｅｃｏ Ｖｉａｎａ／ＴｈｅＮＥＷＳ２ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2023072205273
2023年07月21日Pfizer Facade in New YorkJuly 21, 2023, New York City, New York: (NEW) Pfizer Facade in New York. July 21, 2023, New York, USA: Pfizer factory at Rocky Mount, in North Carolina suffered a severe storm damage due to Tornado, thus affecting its drug supply but with no employees injured. This factory is one of the largest drug manufacturing facilities in the world, producing roughly a quarter of Pfizer‘s sterile injectable medicines like anesthesia, painkillers, anti-infectives and muscle relaxants used by U.S. hospitals,.Credit: Leco Viana/Thenews2 (Foto: Leco Viana/Thenews2/Zumapress) (Credit Image: © Leco Viana/TheNEWS2 via ZUMA Press Wire)、クレジット：©Ｌｅｃｏ Ｖｉａｎａ／ＴｈｅＮＥＷＳ２ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2023072205367
2023年07月21日Pfizer Facade in New YorkJuly 21, 2023, New York City, New York: (NEW) Pfizer Facade in New York. July 21, 2023, New York, USA: Pfizer factory at Rocky Mount, in North Carolina suffered a severe storm damage due to Tornado, thus affecting its drug supply but with no employees injured. This factory is one of the largest drug manufacturing facilities in the world, producing roughly a quarter of Pfizer‘s sterile injectable medicines like anesthesia, painkillers, anti-infectives and muscle relaxants used by U.S. hospitals,.Credit: Leco Viana/Thenews2 (Foto: Leco Viana/Thenews2/Zumapress) (Credit Image: © Leco Viana/TheNEWS2 via ZUMA Press Wire)、クレジット：©Ｌｅｃｏ Ｖｉａｎａ／ＴｈｅＮＥＷＳ２ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2023072205353
2023年07月21日Pfizer Facade in New YorkJuly 21, 2023, New York City, New York: (NEW) Pfizer Facade in New York. July 21, 2023, New York, USA: Pfizer factory at Rocky Mount, in North Carolina suffered a severe storm damage due to Tornado, thus affecting its drug supply but with no employees injured. This factory is one of the largest drug manufacturing facilities in the world, producing roughly a quarter of Pfizer‘s sterile injectable medicines like anesthesia, painkillers, anti-infectives and muscle relaxants used by U.S. hospitals,.Credit: Leco Viana/Thenews2 (Foto: Leco Viana/Thenews2/Zumapress) (Credit Image: © Leco Viana/TheNEWS2 via ZUMA Press Wire)、クレジット：©Ｌｅｃｏ Ｖｉａｎａ／ＴｈｅＮＥＷＳ２ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2023072205277
2024年07月11日Medicine illustrations in Paraguay - 11 Jul 2024.July 11, 2024, Paraguay: In this photo illustration, the Sanofi logo is seen on the box of the medicine Dorflex, used as an analgesic and muscle relaxant. (Credit Image: © Jaque Silva/SOPA Images via ZUMA Press Wire)、クレジット：©Ｊａｑｕｅ Ｓｉｌｖａ／ＳＯＰＡ Ｉｍａｇｅｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2024071203564
- 1
